Tue, November 24, 2020
Mon, November 23, 2020
Fri, November 20, 2020

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $33 on, Nov 23rd, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-33-on-nov-23rd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $28 to $33 on, Nov 23rd, 2020.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020